EORTC research around Quality of Life aims to:
- Develop and refine questionnaires to assess patients’ health-related quality of life in oncology clinical trials, other well-designed research studies and clinical practice
- Collaborate with other EORTC research groups in implementing health-related quality of life studies within their clinical trial programs
- Conduct research to better understand the effects of cancer and its treatment on the health-related quality of life of diverse populations of patients with cancer, across different cultures.
Professionals from various disciplines, including oncologists, radiotherapists, surgeons, psychiatrists, palliative care specialists, psychologists, social workers and research methodologists are involved in developing disease-specific treatment measurement modules to be administered in addition to the core quality of life questionnaire, the EORTC QLQ-C30. The modules, like the core questionnaire, are designed for use in cancer clinical trials, clinical practice and academic research.
For more information about Quality of Life, contact us.
Related NewsAll news
PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI
Follow-up in Gynecological Cancer Survivors: An EORTC QLG-GCG Survivorship Study
Follow-up in Early and Locally Advanced Breast Cancer Patients: An EORTC QLG-BCG- ROG Protocol
A Survivorship Project to understAnd and to impRove long-Term outcomes for Acute myeloid leukemia patients (SPARTA): The SPARTA Platform
Late Toxicity and Long-term Quality of Life in Head and Neck Cancer Survivors
Comparative evaluation of the computer-adaptive EORTC quality of life measures
EORTC research in Quality of Life has led to the creation of the EORTC Quality of Life Questionnaire, which has become one of the standard tools to measure quality of life in cancer clinical trials. The core questionnaire, currently available in over 100 languages, is accompanied by more than 20 fully-validated modules, addressing disease or population-specific concerns.
School of Health Sciences, University of Southampton
Southampton, United Kingdom
Klinicki Bolnicki Centar Rijeka
Mieke Van Hemelrijck
Guy s and St Thomas' NHS - Guy's Hospital
London, United Kingdom